Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Business & Regulation Supply Chain, COVID-19

Strengthening Supply Chains: Download the Thermo Fisher Scientific eBook

sponsored by Thermo Fisher Scientific

Pre-existing weaknesses in pharmaceutical supply chains were unearthed by the COVID-19 pandemic. This free-to-download eBook features insight from Thermo Fisher Scientific and Sanofi.

Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, explains what makes a strong supply chain. In his view, ideal procurement systems should facilitate the launch, manufacture, and distribution of drugs while also insuring against logistical shocks – such as pandemics. He describes how procurement is evolving at Sanofi and why integrated demand planning is crucial. He says, “It [the pandemic] has forced us to focus to secure purchase orders well ahead of time, which ensures demand signalling and requires effective communication with core partners. Even before the pandemic, the progress of biotech innovation had led to a demand surge. The rate of collaboration will continue to increase as manufacturers increasingly appreciate that suppliers’ specialized capabilities provide competitive advantage.”

Christine Callahan, Vice President of the Global Supply Chain for Life Sciences and Bioproduction at Thermo Fisher Scientific, discusses how  suppliers and customers need to reimagine their business models and relationships to succeed in today’s challenging landscape. She explains how the COVID-pandemic has affected Thermo Fisher Scientific, how the company has responded, and how risk can be minimized in supply chains. She says, “Most companies give a nod to disaster planning, but perhaps now we need to reevaluate these plans more often. We need more scenario-based alternatives to remain flexible enough to cope with the impact imposed by a pandemic.”

Finally, Luis (Lucho) Bianchi Pintos, Vice President of Procurement, BioProduction at Thermo Fisher Scientific, discusses what resilience looks like when sourcing – or providing – raw materials during a pandemic – and how industry attitudes have changed in this area. He says, “Maintaining supply chains is very much about managing risk. Companies must identify risk, acknowledge its presence, and understand how it manifests across whole risk, acknowledge its presence, and understand how it manifests across whole processes – a fine balancing act!”

Download the eBook

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register